# Ibrance

NDC: 0069-0486
Generic name: palbociclib
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20200330

FDA application: NDA212436

## Active ingredients

- PALBOCICLIB: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-0486"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0486
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fecbdd7d-b729-41b5-9872-231b8fe104ce